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Abstract
Fall prevention in Western Australian hospitals is monitored with a monthly generic falls assessment/management tool. Whilst this practice is suitable for 
bed ridden patients, it fails to capture the falls risk for older adult mental health patients who are predominantly ambulant and frequently confused. This 
paper describes the development of a specific mental health falls risk management tool (MHFRMT) for use in older adult mental health units. The development 
of this tool evolved from formative focus group research which successfully identified relevant predictors of risks for falls in this population. Corresponding 
management strategies were then developed for each criterion to the assessed levels of risk. Fall prevention management strategies included referral to 
physiotherapists for gait and balance testing, referral to occupational therapists for functional ability status and to podiatry for foot care. 
The new tool was initially piloted across three older adult mental health units in Western Australia with staff feedback resulting in some formatting revisions. 
The tool was then piloted at a fourth older adult mental unit with no further revisions required. The result was a new tool encompassing a weekly assessment 
rather monthly like the current generic falls form. Staff feedback was mainly about the format of the new tool rather than the content, suggesting that future 
studies need to focus on investigating the reliability and validity of the MHFRMT. Finally, although some staff were not happy with the increased work load 
associated with a weekly assessment, the weekly reporting highlighted two key issues in this patient group over three weeks: (1) fluctuating cognition and (2) 
mental state and behaviour changes. Additionally, the medication alert system identified the number of medications that increase falls risk and also indicated 
the risk alert level associated with each medication.
ABBREVIATIONS
MHFRMT: Mental Health Falls Risk Management Tool
INTRODUCTION
The prevention and management of falls across health care 
and community settings continues to be one of the greatest 
challenges in older adult nursing [1]. In 2012, an audit conducted 
across two older adult mental health units (OAMHS) in the 
metropolitan area of Western Australia identified that a number 
of environmental and patient related factors contributed to the 
high number of falls sustained in the units [2]. The inpatients of 
these units were mostly ambulant with neurocognitive deficits 
or mental rather than physical health disorders. Researchers 
found no standardized assessment and management tools were 
available at either service that adequately reflected the unique 
population needs [2]. There was a different falls reporting culture 
across the two units, and discrepancies were found in medication 
prescribing practices. The generic falls risk assessment tool 
FRAT [falls risk assessment tool] was used at one site and FRMT 
[falls risk management tool] at the other. Both these tools have 
different intervention strategies and are used in all wards of the 
respective hospitals [2]. The audit identified the use of a generic 
falls assessment and management form that was completed when 
the patient was admitted to hospital and reviewed monthly with 
minimum standards being identified on the front panel (under 
65 years, no history of falling in the past six months) and if ticked, 
needing no further review [3]. All patients admitted to the OAMHS 
had a falls assessment completed. In the pre-intervention period 
the WA state-wide falls assessment FRMT was completed. More 
than half (52.2%) of those assessed with the FRMT were assessed 
as being at minimal risk of falling and thus were assessed as only 
needing standard interventions for falls prevention during their 
admission to OAMHS [2]. This highlights the lack of specificity of 
the generic falls risk assessment form in the OAMHS population. 
The minimum standards on this generic form were related to 
patients nursed in bed with physical health problems rather than 
an ambulant population with primarily a mental health problem, 
and did not adequately identify the specific falls risk associated 
with an older adult mental health patient such as fluctuating 
mental state and behaviour, medication side effects and 
ambulatory difficulties. Risk factors for falls are more prevalent 
in older people with cognitive impairment than in cognitively 
intact people: impairments of gait and balance are more severe 
[4], psychoactive medications are more commonly prescribed 
[5,6] and orthostatic hypotension is more prevalent [7,8].
Subsequently, six focus groups were conducted between June 
and November 2012 to address this deficit and develop a new 
tool/instrument. Twenty eight participants employed in older 
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adult mental health from the disciplines of nursing, occupational 
therapy, physiotherapy and pharmacy identified criteria 
associated with falls risk specifically related to the older adult 
mental health patient and developed management strategies 
appropriate to the assessed level of risk. The interdisciplinary 
participation reflected the importance of the strengths each 
discipline brought to fall risk prevention and management for 
this patient group. Results of this study are published elsewhere 
[3], but the main three themes identified from the transcripts 
were: “limitations of using generic falls risk assessment and 
management tools”; “assessment of falls risk not currently 
captured on standardized tools”; and “population specific causes 
of falls”. These were the key drivers for the development of a 
specific mental health falls risk management tool (MHFRMT).
Falls among older adults are often a major cause of increased 
morbidity and mortality [9,10], and a common and costly 
complication of hospitalization [11,12], with cognitively impaired 
older people constituting a high-risk group for accidental falls in 
hospitals [13]. Approximately 10% of fatal falls for older adults 
occur in the hospital setting [14] and given the magnitude of falls 
events in the older adult population, an effective and feasible 
screening tool and a comprehensive remediation approach is 
needed [15].
Screening is a process that primarily aims to identify people at 
increased risk of falls, whereas assessment aims to identify factors 
that increase the risk of a fall that can be dealt with by subsequent 
intervention [16]. Several instruments/tools are currently being 
used clinically in hospitals, residential care facilities and in the 
community to estimate a patient’s risk of falling. The STRATIFY 
[17], the Morse Fall Scale [18] and the Hendrich II Fall Risk Model 
[19] are three instruments widely used in clinical practice by 
nurses [20]. Additionally, the Falls Risk Assessment Tool (FRAT) 
assesses recent falls, medications, psychological factors, cognitive 
impairment, vision, mobility, transfers, behaviours, ADLs, 
environment, nutrition, and continence, whilst the CDC Steadi 
tool provides an algorithm to measure risk and guide treatment 
[21]. Many of the well accepted and recognized falls assessment 
and management tools have been demonstrated to be effective 
for general patients who are mainly non-ambulant during their 
hospital admission but appear less relevant in the mental health 
setting where there are populations of highly ambulant patients 
[2]. 
Older adult mental health inpatient populations are 
frequently diagnosed with a neurocognitive disorder or a mental 
disorder as outlined in the Diagnostic and Statistical Manual of 
Mental Health Disorders, Fifth Edition (DSM-V) [22], and the 
International Classification of Disorders (ICD-10) [23]. Cognitive 
deficits are the primary indicator of neurocognitive disorders 
such as dementia and Alzheimer’s and a factor or symptom of 
many mental disorders, for example, schizophrenia, depression 
and bipolar disorder. 
Falls are rarely the result of one factor: for example, age, 
gender, co-morbidities and symptoms of various disease 
processes like diabetes, coronary heart disease and dementia 
can increase the risk for falls [24-29]. While monitoring elderly 
patients with reduced cognitive functioning using a generic 
falls risk form has long been viewed as a cost-effective way to 
reduce the economic and social burden of falls [30], older adults 
with neurocognitive and/or mental disorders have specific falls 
risk factors that benefit from specialized falls assessment and 
management related to fluctuating mental state, medication 
side effects that compromise ambulation and cognition and co-
morbid medical conditions [2,31,32]. In an American study, the 
incidence of falls on older adult psychiatric units was higher than 
that on general acute care units and medication was identified 
as the strongest relationship to a falls episode [33]. People 
with neurocognitive disorders, such as dementia were found to 
be at increased risk of falling [34] and that could be related to 
the fact that antipsychotics are widely used for the treatment 
of behavioural and psychological symptoms of neurocognitive 
disorders [35,36]. The use of these drugs is wide spread with this 
patient population and patients can experience extra pyramidal 
side effects that may affect gait, balance, and reaction times to 
increase the risk of falls [37].
In line with best practice in the care of this patient group these 
risk factors need to be identified on an assessment form with 
a corresponding management strategy. Risk assessment tools 
with corresponding aligned management interventions rather 
than a stand-alone assessment or management tool have been 
identified by several researchers as the best option for reducing 
falls [17,38-42], for example, focussed falls risk management 
specifically targeted to gait improvement and exercise [43] and 
early identification of medication side effects and medication 
prescribing [15].
Furthermore, the areas of importance identified in the focus 
groups for fall prevention in this patient cohort and essential 
for staff to assess were: documented changes in the patient’s 
cognitive state since admission and implemented management 
strategies to address any deficits; an assessment of the patient’s 
fluctuating functional ability; changes in mental state and 
behaviour at regular intervals throughout hospitalisation; 
environmental factors such as flooring, wet areas and outdoor 
obstacles; medical co-morbidities that may compound their 
mental state and medication side effects such as orthostatic 
hypotension, extra pyramidal side effects (EPSE) and sedation. 
Consensus opinion suggested that addressing each assessed 
criteria with a correlated management strategy would decrease 
the fall risk and increase the clinical skills of staff to prevent falls 
in this older adult population. The aim of this paper is to describe 
the development of a mental health falls risk management tool 
to address the deficits identified in the current generic risk 
assessment and management tools.
MATERIALS AND METHODS
Twenty three nurses were surveyed to determine the validity 
of the 20 items assessed in the MHFRMT. The Survey used a 5 item 
Likert scale where 1 = Agree and 5 = Do not agree. Chronbach’s 
alpha for the MHFRMT was 0.948 (A Chronbach’s alpha of over 
0.7 suggests adequate internal consistency for clinical studies) 
[44].
Pilot testing
Pilot testing of the mental health falls risk management tool 
(MHFRMT) initially occurred at three older adult mental health 
units for three weeks in the South Metropolitan area, , with 
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verbal feedback obtained from staff about the advantages of the 
trialled MHFRMT and the barriers they identified in using the 
tool. Occupational therapists, physiotherapists and podiatrists 
involved with the older adult mental health patients were also 
given copies of the MHFRMT for comment and feedback. The 
initial feedback targeted the frequency of recording, given that 
risk assessment was currently performed monthly rather than 
weekly and staffs were concerned with the increased workload 
and accountability. Form usage in practice and formatting issues 
were solved by a three to one vote by staff for a double sided 
form with separate medication alert chart. The medication alert 
chart was well received and considered essential to highlight 
the prescribing patterns and to potentially reduce poly-
pharmacology. Following feedback and amendments to the tool, 
the MHFRMT was pilot tested a second time at a fourth South 
Metropolitan Health service site for three weeks with no further 
adjustments required and the final form was then advanced to 
the medical records/governance committee meetings at each 
of the four sites for validation and an assigned trial number 
consigned for use in the planned clinical trial. The number of beds 
per unit involved with the clinical trial were A= 8; B=26; C=16; 
D=10. Units A and C had a mix of patients with both mental and 
neurocognitive disorders. Unit B had three separate wards: one 
had patients with high dependency needs and neurocognitive 
disorders, one a mix of mental and neurocognitive disorders 
and another with only mental disorders. Unit D had four high 
dependency beds for patients with neurocognitive disorders and 
six beds with a mix of mental and mild neurocognitive disorders.
The process of the form development is represented in Figure 1.
RESULTS AND DISCUSSION
Results: The Mental Health Falls Risk Management 
Tool (MHFRMT)
The final version of the MHFRMT was a four page document 
used in conjunction with a double-sided laminated medication 
tool (see Figure 2a and 2b). The form had tick box spaces that 
allowed staff to assess the patient on three separate occasions 
(this could be weekly over three weeks, or if the patient fell then 
an assessment was recommended immediately and continued 
weekly thereafter). A new form was commenced each third 
week of admission (for longer stay patients) with current data 
transferred across forms. The MHFRMT addressed the criteria 
identified by the focus groups and integrated items recognized as 
useful in this setting from the commonly used generic Falls Risk 
Management Tool (FRMT). Routine monthly fall risk audits are 
completed for all inpatients in hospital in Western Australia, so 
the newly developed MHFRMT needed to comply with the regular 
SQUiRE (Safety and Quality Investment in Reform ) FRMT audits. 
Information captured on the MHFRMT is displayed over 
tables 1-4 and highlights the key elements of the tool. Table 1 
reflects the information deemed most essential and appearing on 
the front page of the form. Refer to “Clinician Alert Level” found 
above the medication section directs the nurse to the laminated 
medication sheet (Figure 2a and 2b) that identifies the fall risk 
level of the patient’s current medication and was a standalone 
form placed in the inner cover of each patient file for easy access 
and consultation.
Page two recorded the seven risk criteria identified by staff 
consensus as relevant for falls; (only 3 criteria: cognitive state, 
functional ability and mental state and behaviour are displayed as 
an example in Table 2). The remaining criteria include: mobility, 
elimination, environmental and medical conditions. 
Page 3 – Management interventions for minimum risk, 
moderate risk and high risk of falling correspond to each of 
the seven risk criteria evaluated, and are opposite each criteria 
(page 2 criteria align with page 3 management strategy for that 
criteria). These management strategies were developed from the 
multidisciplinary staff focus groups in the formative research 
and included referrals to occupational therapy, physiotherapy 
and podiatry as appropriate. Examples of three management 
strategies are in Table 3.
Page 4 – Medication side effect alert levels for specific falls 
risk of postural hypotension, extra pyramidal and sedation 
side effects were identified on the front page with suggested 
interventions for each altered level: As an example, postural 
hypotension is presented below (Table 4). 
As allied health were a source of referral in the management 
strategies, a place for them to respond to a referral and action it 
was added on page four.
The accompanying medication alert tool was crucial for 
assessing the medication risk to falls (Figure 2a and 2b) and 
consisted of a double sided laminated table with most used 
medications (based on available literature) with older adults 
in the general medical field, e.g. Frusemide, statins and opioids 
on one side (2a) and regular use psychiatric medication e.g. 
Risperidone, Sodium Valproate and Diazepam on the other side 
(2b). Each medication recorded had a corresponding alert code: 
green for low risk of falls, amber for moderate risk and red for 
high risk. Those medications yet to be researched for falls risk 
severity were identified with a grey dot, for example Sodium 
Valproate. Medications that patients brought into the hospital 
with a relevant falls alert risk (low, moderate or high as featured 
on the medication alert chart) were also recorded on the front 
panel. This gave a clear picture with an instant visual display of 
falls risk, not otherwise recognised from a mainstream medication 
chart. Doctors and pharmacists could be alerted to the increased 
falls risk attributed to medication with this transparency.
Discussion
The MHFRMT was developed from research literature 
around falls risk assessment and management. It incorporated 
each identified criteria from the focus groups with clinicians 
and married with evidenced based practice guidelines to meet 
the specificity of the older adult mental health population. 
Documentation on the front page of the MHFRMT records any 
visual impairment, hearing deficit and the use of adequate/
correct footwear which is supported by several other researchers 
[25,45].
Many older adult patients with a mental or neurocognitive 
disorder may experience poor decision making, planning 
and judgement; impulsive behaviours; paranoid behaviours; 
misinterpret their environment; have visual/spatial abnormalities 
and a fluctuating course of illness that is not captured on the 
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Identify fall risk in 
older adult mental 
health inpatients








New MHFRMT developed 
for clinical trial
Mental Health services and 
give feedback
Pilot test the form at 3 older adult 
mental health services and give 
feedback
Figure 1 Diagram of form development process.
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associated as cause of falls 
 Moderate – may cause 
falls especially in 
combination 
 Low - Can cause falls 
in combination 
 Associated with falls 
- severity not specified 
 











































































Atropine        
Hyoscine          
Orphenadrine          
Procyclidine          
ACE 
inhibitors
Captopril          
Ramipril          
Enalapril          




Candesartan          
Irbesartan          
losartan          
Apha-
Blockers
Doxazosin          
Prazosin          
Clonidine          
Moxonidine          
Anti-
arrhythmics
Digoxin          
Amiodarone          
Flecainide          
Beta-
blockers
Atenolol          
Propranolol          
Sotalol          
Diuretics Furosemide,          
Bumetanide,          
Bendroflumethia
zide          
Opioid 
analgesics
Morphine,          
Codeine          
Dihydrocodeine          
Tramadol          
Anti-
histamines
Promethazine,          




Amlodipine          
Felodipine          
Nifedipine          
Diltiazem          
Verapamil          
Nitrates Glyceryl 
trinitrate          
Isosorbide 
mononitrate          
Isosorbide 
dinitrate          
 References: ResourcePharm - Medications associated with falls in the elderly http://www.resourcepharm.com/; Medicines and 
Falls in Hospital -http://www.bgs.org.uk/campaigns/fallsafe/Falls_drug_guide.pdf; Medicines management tool for 
Antipsychotics NHS Foundation Trust, http://www.hey.nhs.uk/content/files/prescribingCommittee/guidelines/antipsychotics.pdf;
MIMS online.
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 High - Commonly 
associated as cause of falls 
 Moderate – may cause 
falls especially in 
combination 
 Low - Can cause falls 
in combination 
 Associated with falls 
- severity not specified 
 











































































Atropine        
Hyoscine          
Orphenadrine          
Procyclidine          
ACE 
inhibitors
Captopril          
Ramipril          
Enalapril          




Candesartan          
Irbesartan          
losartan          
Apha-
Blockers
Doxazosin          
Prazosin          
Clonidine          
Moxonidine          
Anti-
arrhythmics
Digoxin          
Amiodarone          
Flecainide          
Beta-
blockers
Atenolol          
Propranolol          
Sotalol          
Diuretics Furosemide,          
Bumetanide,          
Bendroflumethia
zide          
Opioid 
analgesics
Morphine,          
Codeine          
Dihydrocodeine          
Tramadol          
Anti-
histamines
Promethazine,          




Amlodipine          
Felodipine          
Nifedipine          
Diltiazem          
Verapamil          
Nitrates Glyceryl 
trinitrate          
Isosorbide 
mononitrate          
Isosorbide 
dinitrate          
 References: ResourcePharm - Medications associated with falls in the elderly http://www.resourcepharm.com/; Medicines and 
Falls in Hospital -http://www.bgs.org.uk/campaigns/fallsafe/Falls_drug_guide.pdf; Medicines management tool for 
Antipsychotics NHS Foundation Trust, http://www.hey.nhs.uk/content/files/prescribingCommittee/guidelines/antipsychotics.pdf;
MIMS online.
Figure 2a Clinician Alert Level – General Medications.
 High - Commonly associated as 
cause of falls 
 Moderate –
may cause falls 
especially in 
combination 
 Low - Can cause 
falls in combination 
 Associated with falls - severity not 
specified 
 







































































Antidepressants Amitriptyline          
Clomipramine          
Doxepin          
Dothiepin          
Imipramine          
Nortriptyline          
Trimipramine          
Mianserin          
Citalopram          
Escitalopram          
Fluoxetine          
Fluvoxamine          
Paroxetine          
Sertraline          
Duloxetine          
Reboxetine          
Venlafaxine          
Mirtazapine          
Phenelzine          
Tranylcypromine          
Moclobemide          
Antipsychotics Amisulpride          
Aripripazole          
Clozapine          
Chlorpromazine          
Olanzapine          
Paliperidone          
Quetiapine          
Risperidone          
Zotepine          
Ziprasidone          
Flupentixol          
Fluphenazine          
Haloperidol          
Pipotiazine          
Sertindole          
Sulpiride          
Trifluoperazine          
Zuclopenthixol          
Sedatives Diazepam          
Temazepam          
Nitrazepam          
Lorazepam          
Oxazepam          
Clonazepam          
Zopiclone          
Zolpiderm          
Dopamine 
agents
Co-beneldopa          
Co-careldopa          
Bromocriptine          
Ropinirole          
Pramipexole          
Rotigotine          
Anticonvulsants Phenytoin,          
Carbamazepine          
Sodium Valproate          
Lamotrigine          
Opioids Morphine,          
Codeine          
Dihydrocodeine          
Tramadol          
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 High - Commonly associated as 
cause of falls 
 Moderate –
may cause falls 
especially in 
combination 
 Low - Can cause 
falls in combination 
 Associated with falls - severity not 
specified 
 







































































Antidepressants Amitriptyline          
Clomipramine          
Doxepin          
Dothiepin          
Imipramine          
Nortriptyline          
Trimipramine          
Mianserin          
Citalopram          
Escitalopram          
Fluoxetine          
Fluvoxamine          
Paroxetine          
Sertraline          
Duloxetine          
Reboxetine          
Venlafaxine          
Mirtazapine          
Phenelzine          
Tranylcypromine          
Moclobemide          
Antipsychotics Amisulpride          
Aripripazole          
Clozapine          
Chlorpromazine          
Olanzapine          
Paliperidone          
Quetiapine          
Risperidone          
Zotepine          
Ziprasidone          
Flupentixol          
Fluphenazine          
Haloperidol          
Pipotiazine          
Sertindole          
Sulpiride          
Trifluoperazine          
Zuclopenthixol          
Sedatives Diazepam          
Temazepam          
Nitrazepam          
Lorazepam          
Oxazepam          
Clonazepam          
Zopiclone          
Zolpiderm          
Dopamine 
agents
Co-beneldopa          
Co-careldopa          
Bromocriptine          
Ropinirole          
Pramipexole          
Rotigotine          
Anticonvulsants Phenytoin,          
Carbamazepine          
Sodium Valproate          
Lamotrigine          
Opioids Morphine,          
Codeine          
Dihydrocodeine          
Tramadol          
Figure 2b Clinician Alert Level – CNS medications.
Table 1: Front page of MHFRMT.
Previous falls within last 6 months (date/injury)
Date __/__/__
Injury?  Yes  No Date __/__/__Injury?  Yes  No
Date __/__/__
Injury?  Yes  No
Date __/__/__
Injury?  Yes  No
Date __/__/__
Injury?  Yes  No
Mini Mental State
 Examination Score (MMSE)(or 
similar)_______________
Physical observations on admission
Temp Pulse BP sitting/lying BP standing
Does the patient report unsteadiness/
dizziness?              
Yes   No
Visual and hearing (tick)  Normal vision Normal hearing     Wears spectacles  
                                                      Hearing Aid    Left    Right
Foot wear (tick) Does the person have well-fitting footwear with a non-slip sole?  Yes    No
Education Has the patient and family been provided information about the risk of falling and safety
Issues?  Yes    No
Medications on Admission
Is the patient on any medication at admission that is known to cause side effects associated with falls?  Refer to ‘Clinician Alert Level’ and 
enter the medication and circle alerts according to the code below
Medication name Dose Frequency Route Alert level (Circle High and Moderate alerts)
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Tohotoa et al. (2016)
Email: 
Ann Nurs Pract 3(1): 1039 (2016) 7/10
A    B    C    D    E    F    G    H    I
A    B    C    D    E    F    G    H    I
A    B    C    D    E    F    G    H    I
A    B    C    D    E    F    G    H    I
A    B    C    D    E    F    G    H    I
A    B    C    D    E    F    G    H    I
A    B    C    D    E    F    G    H    I
A    B    C    D    E    F    G    H    I
Code
A Drowsiness B Dizziness C Confusion Dand  Blood pressure E Gait disturbance
F Cardiac issues G Visual Disturbances H EPSE I  Slowed Reactions
Medications (tick all that apply) 
1 2 3 Implemented level of Intervention   Date Initial
Have any medications changed since admission? 
  Yes   No    1 2 3
Patient has Postural hypotension (see back page) 1 2 3
Patient has Extra Pyramidal Side Effects (EPSE) (see back page) 1 2 3
Patient is Sedated (see back page) 1 2 3
Abbreviations: EPSE: Extrapyramidal Side Effects; MMSE: Mini Mental State Examination
Table 2: Assessment table for cognitive state, functional ability and mobility.
Cognitive State (tick all that apply) 
Implemented  level of Intervention   (circle) Date Initial
Normal   1 2 3
Disorientated    1 2 3
Confused  1 2 3
Functional Ability (tick all that apply)
Implemented  level of Intervention   (circle) Date Initial
Independent with all tasks  1 2 3
Requires reassurance or verbal prompts 1 2 3
Requires assistance with ADLs
 1 person    2 person  1 2 3
 Mental state and behaviour(tick all that apply) 
Implemented  level of Intervention   (circle) Date Initial
Cooperative/follows direction 1 2 3
Uncooperative/unable to follow direction 1 2 3
Impaired judgment/poor insight 1 2 3
Verbally aggressive 1 2 3
Physically aggressive 1 2 3
Depressed mood 1 2 3
Elevated mood 1 2 3
Intoxicated 1 2 3
Evidence of psychosis 1 2 3
 - Perceptual disturbance 1 2 3
 - Paranoia 1 2 3
 - Formal thought disorder 1 2 3
Abbreviations: ADLs: Aids to Daily Living
Central
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generic form in current use. The levels of intervention for 
cognitively impaired older adults in the MHFRMT reflect the 
outcomes of research by Kallin et al., (2005) who found an 
intervention strategy would probably have to include treatment 
of psychiatric and behavioural symptoms, improvement of gait 
and balance and adjustment of drug treatment [46]. 
Elimination and continence were important criteria to assess 
for falls risk as more frequent toileting needs increased the falls 
risk. With older adult mental health inpatients this could be 
associated with an increased thirst related to medication-induced 
dryness of the mouth, and lead to a greater need to urinate 
multiple times at night, further increasing the prospect for falls 
[47]. With an ambulant population the need for environmental 
control and good hospital design is paramount [28]. Some 
environmental factors associated with falls risk are obstructed 
walkways, inadequate lighting, slippery floors and surfaces and 
lack of handrails in stairways [25], and these are highlighted in 
the MHFRMT criteria with corresponding management strategies 
to reduce the risk.
The strength of the MHFRMT is the comprehensive covering 
of all domains identified as important and relevant in the 
formative research and from current literature. The medication 
panel with a visual display of high, moderate or low alert for falls 
risk is an innovative addition that allows all staff to immediately 
see the number of medications that carry a falls risk alert and the 
strength of those alerts. This can highlight the need for prescribing 
changes that may have gone unnoticed. Two drug categories 
that proved to carry a statistically significant, independent fall 
risk were antiepileptic and benzodiazepine medications, thus, 
a patient taking one of these drugs could be at greater risk for 
falling than a patient taking five or six medications from other 
drug categories [48]. The medication panel on the front page 
would identify that risk.
Many older adult mental health patients have multiple co-
morbidities and the combination of medications used to treat their 
primary presenting illness and their co-morbidities is a specific 
falls risk factor for these patients [3]. Medication with strongest 
links to an increased risk of falling include antidepressants [49], 
antipsychotic agents [50], benzodiazepines, anticonvulsants 
[37,51] and anti arrythmics [52]. The recognition of this is 
evident in the MHFRMT with a separate section devoted to these 
medication side effects with appropriate management strategies. 
Nurses must be taught to vigilantly observe patients for side 
effects of medications, especially after recent changes. Careful 
assessment and tracking of vital signs for patients on complex 
or new medication regimens may provide advance warning of 
physiological instability leading to falls. Orthostatic hypotension 
increases the risk for falls by inhibiting balance and mobility 
[53], and lying and standing blood pressure monitoring was 
recommended on the MHFRMT as routine for this patient cohort. 
Nurses should be particularly concerned about postural blood 
pressure changes greater than 20 mmHg and pulse rates greater 
than 100 [54].
A limitation of the MHFRMT is associated with staff feedback 
which was mainly about the format of the new tool rather than 
the content, suggesting that future studies need to focus on 
investigating the reliability and validity of the MHFRMT.
CONCLUSION
The MHFRMT incorporated all the criteria suggested from 
previous studies to capture the total picture of risk for the 
older adult mental health patient. The weekly reporting regime 




Use clear concise communication 
Assess and document need for supervision in toilet 
and shower
Level 2
As for level 1 +
Assess /consider 15/60 or 30/60 visual 
observations
Supervise toilet and shower at all times
Assess mental state and commence behaviour 
observation chart as appropriate
Review medications with team
Place bed against the wall and use appropriate 
equipment (alarm mat, low bed etc if appropriate 
to mental state)
Refer to OT for cognitive assessment
Level 3
As for level 1 and 2 +
Nurse in communal areas where possible
Segregate from other patients if appropriate
Supervise toilet and shower at all times
Review behaviour observation chart and 
mental state – medical review if indicated




Assess areas of patient’s strength and try to 
encourage activity in these areas.
Encourage physical and cognitively challenging 
activities
Provide appropriate aids for ADLs
Level 2
As for level 1 +
Occupational therapy assessment for aids
Assist with mobilisation and ADL’s as necessary
Level 3
As for level 1 and 2 +
Consider nursing 1:1 with identified 
management plan 
Mental state and behaviour
Level 1
Routine visual observations
Use clear concise communication rapport
Educate patient and family
Supportive normative behaviours
Ongoing mental state assessment
Level 2
As for Level 1 +
Review medications – effective
Engage in diversional/distracting activities 
Consider 15/60 or 30/60 visual  observations
Level 3 
As for Level 1 and 2 +
Consider nursing 1:1 with identified 
management plan 
Segregate from other patients if appropriate
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highlighted the fluctuating cognition and behaviour changes that 
could be experienced in this patient group over a three week 
period and the medication alert system identified not only the 
number of medications that could increase the falls risk but 
also the risk alert level of each medication. Reduced falls lead to 
fewer complications occurring in patients during hospitalisation 
further improving access to services, cost efficiencies and 
improved patient flow through all inpatient older adult mental 
health services. A reduction in falls also means that more of these 
patients will successfully be returned to their community and 
will not need alternative accommodation and specialist follow up 
care as a result of falling. 
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Low blood pressure or recent change 
in medication
Moderate Alert
Drop in systolic pressure 10-20mmHg 
within 3 minutes of standing
Dizziness on rising, light headedness, 
feeling faint
High Alert
Drop in systolic pressure >20mmHg 
within 3 minutes of standing
Buckling of legs, cognitive slowing, 
headache
Interventions
MonitorBP daily (lying and standing)
Monitor for signs of postural 
hypotension
Education - encourage to mobilise in 
steps - sit on side of bed, then stand
As for Low Alert +
Assess for symptoms of postural BP before 
mobilizing - dizziness, feeling faint
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night, limit carbohydrates
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As for Moderate Alert +
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Raise head of bed 5 - 20 degrees
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